Findings

What do systematic reviews say?

2,234 questions · 2,325 findings · 216 reviews · Airways

Sort:Best matchNewestHighest certainty Download CSV

No studies found 249 · 10.7%GRADE not reported 107 · 4.6%Very low 276 · 11.9%Low 751 · 32.3%Moderate 718 · 30.9%High 224 · 9.6%

Hypnotics vs inactive control

Quality of sleep · adults with primary central sleep apnoea

The review found no eligible studies for this question.

1 finding from 1 review

Pharmacological treatment for central sleep apnoea in adults 2023 · Cochrane Headline outcomes only
no estimate extracted
Studies not reported
No studies found

Hypnotics vs inactive control

Quality of lifeÂ · adults with primary central sleep apnoea

The review found no eligible studies for this question.

1 finding from 1 review

Pharmacological treatment for central sleep apnoea in adults 2023 · Cochrane Headline outcomes only
no estimate extracted
Studies not reported
No studies found

Hypnotics vs inactive control

AHI · adults with primary central sleep apnoea

1 finding from 1 review

Pharmacological treatment for central sleep apnoea in adults 2023 · Cochrane Headline outcomes only
no estimate extracted
1 study · 5 participants
GRADE not reported

Hypnotics vs inactive control

All‐cause mortality · adults with primary central sleep apnoea

The review found no eligible studies for this question.

1 finding from 1 review

Pharmacological treatment for central sleep apnoea in adults 2023 · Cochrane Headline outcomes only
no estimate extracted
Studies not reported
No studies found

Carbonic anhydrase inhibitors vs inactive control

Serious adverse events · adults with central sleep apnoea associated with heart failure

The review found no eligible studies for this question.

1 finding from 1 review

Pharmacological treatment for central sleep apnoea in adults 2023 · Cochrane Headline outcomes only
no estimate extracted
Studies not reported
No studies found

Carbonic anhydrase inhibitors vs inactive control

Quality of sleep · adults with central sleep apnoea associated with heart failure

The review found no eligible studies for this question.

1 finding from 1 review

Pharmacological treatment for central sleep apnoea in adults 2023 · Cochrane Headline outcomes only
no estimate extracted
Studies not reported
No studies found

Carbonic anhydrase inhibitors vs inactive control

Quality of life · adults with central sleep apnoea associated with heart failure

The review found no eligible studies for this question.

1 finding from 1 review

Pharmacological treatment for central sleep apnoea in adults 2023 · Cochrane Headline outcomes only
no estimate extracted
Studies not reported
No studies found

Carbonic anhydrase inhibitors vs inactive control

AHI · adults with central sleep apnoea associated with heart failure

2 findings from 1 review

Pharmacological treatment for central sleep apnoea in adults 2023 · Cochrane Headline outcomes only
no estimate extracted
1 study · 12 participants
Very low
Pharmacological treatment for central sleep apnoea in adults 2023 · Cochrane Headline outcomes only
no estimate extracted
1 study · 18 participants
Very low

Carbonic anhydrase inhibitors vs inactive control

All‐cause mortality · adults with central sleep apnoea associated with heart failure

The review found no eligible studies for this question.

1 finding from 1 review

Pharmacological treatment for central sleep apnoea in adults 2023 · Cochrane Headline outcomes only
no estimate extracted
Studies not reported
No studies found

Anxiolytics vs inactive control

cAHI · adults with central sleep apnoea associated with heart failure

1 finding from 1 review

Pharmacological treatment for central sleep apnoea in adults 2023 · Cochrane Headline outcomes only
no estimate extracted
1 study · 16 participants
GRADE not reported

Pulmonary rehabilitation plus inspiratory muscle training vs pulmonary rehabilitation alone

Dyspnea · patients with chronic obstructive pulmonary disease

2 findings from 1 review

Inspiratory muscle training, with or without concomitant pulmonary rehabilitation, for chronic obstructive pulmonary… 2023 · Cochrane Headline outcomes only
no estimate extracted
2 studies · 202 participants
Moderate
Inspiratory muscle training, with or without concomitant pulmonary rehabilitation, for chronic obstructive pulmonary… 2023 · Cochrane Headline outcomes only
no estimate extracted
2 studies · 204 participants
Very low

Inspiratory muscle training vs control or sham

Functional exercise capacity · patients with chronic obstructive pulmonary disease

1 finding from 1 review

Inspiratory muscle training, with or without concomitant pulmonary rehabilitation, for chronic obstructive pulmonary… 2023 · Cochrane Headline outcomes only
no estimate extracted
16 studies · 501 participants
Moderate

Inspiratory muscle training vs control or sham

Health‐related quality of life · patients with chronic obstructive pulmonary disease

2 findings from 1 review

Inspiratory muscle training, with or without concomitant pulmonary rehabilitation, for chronic obstructive pulmonary… 2023 · Cochrane Headline outcomes only
no estimate extracted
6 studies · 182 participants
Very low
Inspiratory muscle training, with or without concomitant pulmonary rehabilitation, for chronic obstructive pulmonary… 2023 · Cochrane Headline outcomes only
no estimate extracted
2 studies · 86 participants
Moderate

Inspiratory muscle training vs control or sham

Inspiratory muscle strength · patients with chronic obstructive pulmonary disease

1 finding from 1 review

Inspiratory muscle training, with or without concomitant pulmonary rehabilitation, for chronic obstructive pulmonary… 2023 · Cochrane Headline outcomes only
no estimate extracted
32 studies · 916 participants
Low

Pulmonary rehabilitation plus inspiratory muscle training vs pulmonary rehabilitation alone

Functional exercise capacity · patients with chronic obstructive pulmonary disease

1 finding from 1 review

Inspiratory muscle training, with or without concomitant pulmonary rehabilitation, for chronic obstructive pulmonary… 2023 · Cochrane Headline outcomes only
no estimate extracted
12 studies · 1199 participants
Very low

Pulmonary rehabilitation plus inspiratory muscle training vs pulmonary rehabilitation alone

Health‐related quality of life · patients with chronic obstructive pulmonary disease

2 findings from 1 review

Inspiratory muscle training, with or without concomitant pulmonary rehabilitation, for chronic obstructive pulmonary… 2023 · Cochrane Headline outcomes only
no estimate extracted
7 studies · 908 participants
Low
Inspiratory muscle training, with or without concomitant pulmonary rehabilitation, for chronic obstructive pulmonary… 2023 · Cochrane Headline outcomes only
no estimate extracted
2 studies · 657 participants
Very low

Pulmonary rehabilitation plus inspiratory muscle training vs pulmonary rehabilitation alone

Inspiratory muscle strength · patients with chronic obstructive pulmonary disease

1 finding from 1 review

Inspiratory muscle training, with or without concomitant pulmonary rehabilitation, for chronic obstructive pulmonary… 2023 · Cochrane Headline outcomes only
no estimate extracted
17 studies · 1329 participants
Moderate

Inspiratory muscle training vs control or sham

Dyspnea · patients with chronic obstructive pulmonary disease

3 findings from 1 review

Inspiratory muscle training, with or without concomitant pulmonary rehabilitation, for chronic obstructive pulmonary… 2023 · Cochrane Headline outcomes only
no estimate extracted
6 studies · 144 participants
Very low
Inspiratory muscle training, with or without concomitant pulmonary rehabilitation, for chronic obstructive pulmonary… 2023 · Cochrane Headline outcomes only
no estimate extracted
8 studies · 238 participants
Very low
Inspiratory muscle training, with or without concomitant pulmonary rehabilitation, for chronic obstructive pulmonary… 2023 · Cochrane Headline outcomes only
no estimate extracted
4 studies · 150 participants
Low

Intervention not reported

Total studies: 17 RCTs Total participants: 22,819 · adolescents and adults with uncontrolled asthma, despite being on medium‐dose ICS Interventions: HD‐ICS, LD‐ICS/LABA, MD‐ICS/LAMA,…

1 finding from 1 review

Addition of long‐acting beta2 agonists or long‐acting muscarinic antagonists versus doubling the dose of inhaled… 2023 · Cochrane Headline outcomes only
no estimate extracted
17 studies · 22819 participants
GRADE not reported

Intervention not reported

LD‐ICS/LABA (Direct evidence; 0 RCTs; 0 participants) · adolescents and adults with uncontrolled asthma, despite being on medium‐dose ICS Interventions: HD‐ICS, LD‐ICS/LABA, MD‐ICS/LAMA,…

1 finding from 1 review

Addition of long‐acting beta2 agonists or long‐acting muscarinic antagonists versus doubling the dose of inhaled… 2023 · Cochrane Headline outcomes only
no estimate extracted
0 studies · 0 participants
Low